Search in:

OncoTargets and Therapy Volume 10, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Review

The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis

Zaoxiu Hu1 Department of Pathology

Yanlong Yang2 Department of Thoracic Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital)

Yonghe Zhao3 Department of Pathology, The Forensic School of Kunming Medical University

Yunchao Huang2 Department of Thoracic Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital);4 Cancer Research Institute of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan Province, People’s Republic of ChinaCorrespondence[email protected]

Pages 2893-2901 | Published online: 09 Jun 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (20)

Xiaobo Song, Ole K. Greiner-Tollersrud & Huimin Zhou. (2021) Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal Cancer. Digestive Diseases and Sciences 67:8, pages 3543-3556.
Crossref

David Jay Wilson & Raymond N. DuBois. (2022) Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer. Cancer Prevention Research 15:6, pages 355-363.
Crossref

Jiang Jiang, Junfeng Liu, Ping Gao & Junying Liu. (2022) Effect of taking aspirin before diagnosis on the prognosis of esophageal squamous cell carcinoma and analysis of prognostic factors. Journal of International Medical Research 50:4, pages 030006052210897.
Crossref

Man Kit Cheung, Grace Gar‐Lee Yue, Adele Joyce Gomes, Eric Chun‐Wai Wong, Julia Kin‐Ming Lee, Frankie Hin‐Fai Kwok, Philip Wai‐Yan Chiu & Clara Bik‐San Lau. (2022) Network pharmacology reveals potential functional components and underlying molecular mechanisms of Andrographis paniculata in esophageal cancer treatment . Phytotherapy Research 36:4, pages 1748-1760.
Crossref

Yukti Hari Gupta, Abida Khanom & Sophie E. Acton. (2022) Control of Dendritic Cell Function Within the Tumour Microenvironment. Frontiers in Immunology 13.
Crossref

Dingzhi Wang, Carlos S. Cabalag, Nicholas J. Clemons & Raymond N. DuBois. (2021) Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer. Gastroenterology 161:6, pages 1813-1829.
Crossref

Yanhu Xie, Di Wang, Chen Gao, Jicheng Hu, Min Zhang, Wei Gao, Shuhua Shu & Xiaoqing Chai. (2021) Effect of perioperative flurbiprofen axetil on long‐term survival of patients with esophageal carcinoma who underwent thoracoscopic esophagectomy: A retrospective study. Journal of Surgical Oncology 124:4, pages 540-550.
Crossref

Maria Davern, Noel E. Donlon, Robert Power, Conall Hayes, Ross King, Margaret R. Dunne & John V. Reynolds. (2021) The tumour immune microenvironment in oesophageal cancer. British Journal of Cancer 125:4, pages 479-494.
Crossref

Megan R. Gillespie, Vikrant Rai, Swati Agrawal & Kalyana C. Nandipati. (2021) The Role of Microbiota in the Pathogenesis of Esophageal Adenocarcinoma. Biology 10:8, pages 697.
Crossref

Jiahua Cui & Jinping Jia. (2021) Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update. Current Medicinal Chemistry 28:18, pages 3622-3646.
Crossref

Dan Pu, Liyuan Yin, Lin Huang, Changlong Qin, Yuwen Zhou, Qiang Wu, Yan Li, Qinghua Zhou & Lu Li. (2021) Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer. Frontiers in Oncology 11.
Crossref

Łukasz Kuźbicki & Anna A. Brożyna. (2019) Immunohistochemical detectability of cyclooxygenase‐2 expression in cells of human melanocytic skin lesions: A methodological review. Journal of Cutaneous Pathology 47:4, pages 363-380.
Crossref

Kieran G Foley, Adam Christian, James Peaker, Christopher Marshall, Emiliano Spezi, Howard Kynaston & Ashley Roberts. (2019) Cyclo-oxygenase-2 expression is associated with mean standardised uptake value on 18F-Fluorodeoxyglucose positron emission tomography in oesophageal adenocarcinoma. The British Journal of Radiology 92:1099, pages 20180668.
Crossref

Mohamed Ali Alabiad, Ola A. Harb, Heba F. Taha, Basant Sh El Shafaay, Loay M. Gertallah & Nashaat Salama. (2018) Prognostic and Clinic-Pathological Significances of SCF and COX-2 Expression in Inflammatory and Malignant Prostatic Lesions. Pathology & Oncology Research 25:2, pages 611-624.
Crossref

Andrew D Spence, James Trainor, Úna McMenamin, Richard C Turkington, Stephen McQuaid, Victoria Bingham, Jacqueline James, Manuel Salto-Tellez, Damian T McManus, Brian T Johnston, Chris R Cardwell & Helen G Coleman. (2019) High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study. Histopathology 74:4, pages 587-596.
Crossref

Mohammad Fahad Ullah, Showket H. Bhat, Muhammad Tariq & Faisel M. Abuduhier. 2019. Biocatalysis. Biocatalysis 213 231 .

Esraa Saadi, Sharon Tal & Liza Barki-Harrington. (2018) Substrate-inactivated cyclooxygenase-2 is disposed of by exosomes through the ER–Golgi pathway. Biochemical Journal 475:19, pages 3141-3151.
Crossref

Rachana Garg, Jorge M. Blando, Carlos J. Perez, Priti Lal, Michael D. Feldman, Emer M. Smyth, Emanuela Ricciotti, Tilo Grosser, Fernando Benavides & Marcelo G. Kazanietz. (2018) COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer. Oncogene 37:34, pages 4735-4749.
Crossref

Dingzhi Wang & Raymond N. DuBois. (2018) Role of prostanoids in gastrointestinal cancer. Journal of Clinical Investigation 128:7, pages 2732-2742.
Crossref

Marco Aurélio Petroni Montezuma, Felipe Paiva Fonseca, Bernar Monteiro Benites, Ciro Dantas Soares, Gleyson Kleber do Amaral-Silva, Oslei Paes de Almeida, Fernando Augusto Soares, Rosana Lima Pagano & Eduardo Rodrigues Fregnani. (2018) COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma. Pathology - Research and Practice 214:6, pages 907-913.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis

Articles from other publishers (20)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis

Citations (20)

Articles from other publishers (20)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date